Royal Bank of Canada
BDSX icon

Royal Bank of Canada’s Biodesix BDSX Stock Holding History

Royal Bank of Canada’s Portfolio BDSX Stock Details BDSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-8,901
Closed -$67K – 7161
2025
Q3 		$67K Buy
+8,901
New +$68.5K ﹤0.01% 5696
2024
Q3 		– Sell
-8
Closed – – 6850
2024
Q2 		$0 Buy
+8
New +$228 ﹤0.01% 7046
2022
Q2 		– Sell
-43
Closed -$1K – 7366
2022
Q1 		$1K Sell
43
-112
-72% -$7.32K ﹤0.01% 7568
2021
Q4 		$16K Buy
155
+74
+91% +$9.66K ﹤0.01% 6882
2021
Q3 		$13K Buy
81
+39
+93% +$7.4K ﹤0.01% 6862
2021
Q2 		$11K Buy
42
+22
+110% +$6.92K ﹤0.01% 6829
2021
Q1 		$8K Buy
20
+11
+122% +$4.91K ﹤0.01% 6883
2020
Q4 		$4K Buy
+9
New +$2.8K ﹤0.01% 6717

Other funds holding BDSX

TAM
Telemark Asset Management Boston, Massachusetts $1.08B AUM 70.88% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Royal Bank of Canada's BDSX Position: Q4 2025 in Review

Royal Bank of Canada sold out of Biodesix (BDSX) in Q4 2025, closing a stake of 8,901 shares — an estimated $67K sold.

Royal Bank of Canada first reported a position in BDSX in Q4 2020 and held it in 8 quarters. The position peaked at $67K in Q3 2025. 26 funds tracked by Wall St. Rank hold BDSX as of Q4 2025.

  • Royal Bank of Canada reported no remaining Biodesix position as of Q4 2025 after selling out during the quarter.
  • Royal Bank of Canada sold 8,901 Biodesix shares in Q4 2025, an estimated $67K.
  • Royal Bank of Canada first reported a position in Biodesix in Q4 2020 and held it in 8 quarters.
  • Royal Bank of Canada's Biodesix position peaked at $67K in Q3 2025.
  • 26 funds tracked by Wall St. Rank held Biodesix as of Q4 2025.

Based on Royal Bank of Canada's 13F filing for Q4 2025, filed 17 Feb 2026.